ABSTRACT This review provides an overview of the relationship between ventilation/perfusion ratios and gas exchange in the lung, emphasising basic concepts and relating them to clinical scenarios. For each gas exchanging unit, the alveolar and effluent blood partial pressures of oxygen and carbon dioxide (PO 2 and PCO 2 ) are determined by the ratio of alveolar ventilation to blood flow (V9A/Q9) for each unit. Shunt and low V9A/Q9 regions are two examples of V9A/Q9 mismatch and are the most frequent causes of hypoxaemia. Diffusion limitation, hypoventilation and low inspired PO 2 cause hypoxaemia, even in the absence of V9A/Q9 mismatch. In contrast to other causes, hypoxaemia due to shunt responds poorly to supplemental oxygen. Gas exchanging units with little or no blood flow (high V9A/Q9 regions) result in alveolar dead space and increased wasted ventilation, i.e. less efficient carbon dioxide removal. Because of the respiratory drive to maintain a normal arterial PCO 2 , the most frequent result of wasted ventilation is increased minute ventilation and work of breathing, not hypercapnia. Calculations of alveolar-arterial oxygen tension difference, venous admixture and wasted ventilation provide quantitative estimates of the effect of V9A/Q9 mismatch on gas exchange. The types of V9A/Q9 mismatch causing impaired gas exchange vary characteristically with different lung diseases. @ERSpublications A review of ventilation-perfusion relationships and gas exchange, basic concepts and their relation to clinical cases
Introduction
While the healthy lung efficiently exchanges respiratory gases, hypoxaemia and hypercapnia indicate pathophysiology and failure of the lung to provide adequate gas exchange. An understanding of how gases are transferred and the causes of inefficient gas exchange are central to caring for patients with lung diseases. In this article, we will review the normal and pathological mechanisms of gas exchange. Starting with simple and building to more complex, we will emphasise basic concepts and relate them to case scenarios familiar to clinicians.
Lung structure
The structure of the lung is well suited for efficient exchange of respiratory gases. Through the airway and vascular trees, fresh gases and venous blood are delivered to and removed from a large alveolar capillary surface area. In an adult, inhaled air enters the trachea with a cross-sectional area of ,3 cm 2 and is delivered to the alveoli with a surface area of ,140 m 2 , roughly the size of a tennis court [1] . Similarly, the pulmonary vascular tree begins as the main pulmonary artery and repeatedly bifurcates into arterioles and capillaries that cover 85-95% of the alveolar surface [1] . An exceptionally thin membrane of only 1 mm [2, 3] separates the alveolar gas and blood compartments, allowing gases to diffuse rapidly between them. Due to the relatively large blood volume within the alveolar capillaries, blood flow slows and the transit time for blood increases, normally to 0.25-0.75 s, allowing more time for gas exchange. The remarkable design that allows this gas exchanging system to be constructed within the thoracic cavity has been highlighted by comparing this engineering feat to that of folding a letter so that it fits into a thimble [3] .
A single lung unit
We start with a simple lung model consisting of just one gas exchanging unit ( fig. 1a ). The capillaries of the unit deliver mixed venous blood with a low partial pressure of O 2 (PvO 2 ). The partial pressure of O 2 (PO 2 ) in the alveolar gas (PAO 2 ) is much higher than in the capillary blood and O 2 diffuses passively from the alveolar space into the blood during passage through the capillaries ( fig. 2a) . The membrane separating the alveolar gas and blood compartments causes little resistance to diffusion so the PO 2 in end-capillary blood (PecO 2 ) equilibrates with PAO 2 well before the blood leaves the unit. Oxygenation of arterial blood is, therefore, primarily dependent on the PAO 2 . Note that in this idealised lung unit there is no difference between PAO 2 and PO 2 in arterial blood (PaO 2 ). For reasons explained later, the alveolar-arterial O 2 tension difference (PA-aO 2 ) is very helpful when assessing the causes of gas exchange problems in clinical medicine and we will use it throughout this review. While the term ''gradient'' is also commonly used, we prefer to use ''difference'' to highlight that the difference between the PAO 2 and PaO 2 is not due to a pressure gradient between them. The partial pressure of CO 2 (PCO 2 ) is greater in mixed venous blood (PvCO 2 ) than in the alveolar gas (PACO 2 ) and diffusion over the alveolar-capillary membrane, therefore, results in a net flow in a direction opposite to that of O 2 , from blood to alveolar gas ( fig. 2b ). The result is again an equal PCO 2 in alveolar gas and end-capillary blood (PecCO 2 ) because the resistance for diffusion is even less for CO 2 than for O 2 . Due to differences in the relationship between partial pressures and blood content for O 2 and CO 2 , there is approximately as much CO 2 exchanged for a partial pressure difference between mixed venous and arterial blood of 5 mmHg (0.7 kPa) as there is O 2 exchanged with a difference of 60 mmHg (6.7 kPa). The amount of O 2 carried in the blood is determined by the haemoglobin concentration, the fraction of haemoglobin binding O 2 and the PaO 2 ( fig. 1b) . When we discuss multiple lung unit models below, it is important to understand that the end-capillary blood O 2 content (CecO 2 ), rather than the PecO 2 , from different units are additive.
Five causes of arterial hypoxaemia
A single-unit model ( fig. 1a ) is used to begin our discussion of five potential causes of hypoxaemia as well as hypercapnia. Our first example is one of diffusion limitation.
Diffusion limitation
In case 1, a 25-year-old male elite cyclist who undergoes a cardiopulmonary exercise study is noted to have progressively worsening arterial hypoxaemia with increasing workload (a response not seen in normal individuals). Arterial blood gases (ABGs) at end-exercise are: pH 7.18, PCO 2 in arterial blood (PaCO 2 ) 30 mmHg (4.0 kPa), PaO 2 81 mmHg (10.8 kPa) and arterial haemoglobin O 2 saturation 88%.
Exercise increases the amount of O 2 extracted from arterial blood in the systemic circulation, which tends to reduce PvO 2 . Therefore, more O 2 needs to be taken up in the lung to reach normal oxygenation of arterial blood. Exercise also increases pulmonary blood flow, which shortens the time that the blood is exposed to alveolar gas. The combined effect is that more O 2 needs to be taken up in less time ( fig. 3 ). At very high cardiac outputs, the transit time might be too short for complete equilibration between PAO 2 and PecO 2 . This represents diffusion limitation as a cause of hypoxaemia in athletes achieving extremely high cardiac outputs [4] [5] [6] . Hypoxaemia due to diffusion limitation can also be seen in normal individuals during exercise at altitude. In this setting, the driving pressure for O 2 diffusion is decreased due to the lower PO 2 in inspired air (PIO 2 ) at altitude and the transit time of blood through the alveolar capillaries is shorter due to higher cardiac outputs. A diffusion limitation can also occur in patients with interstitial lung diseases. Patients with these diseases might have a normal PaO 2 at rest but develop hypoxaemia during exercise, which can be explained by the combined effect of increased resistance to diffusion through the thickened alveolar-capillary membrane, reduced PvO 2 and a shortened transit time [7] .
Diffusion limitation is one of five causes of hypoxaemia ( This case highlights hypoventilation as a cause of hypoxaemia. Although the quantitative relationship is complex [8, 9] , it can be intuitively understood that PAO 2 in our single alveolar unit ( fig. 1a) is influenced by the ratio between O 2 delivery (ventilation, V9A) and O 2 removal (blood flow, Q9). Hence, one of the determinants of PAO 2 is the balance or ratio between ventilation and blood flow (V9A/Q9). In the patient from case 2, hypoventilation and normal blood flow results in a low V9A/Q9 ratio (less delivery and unchanged removal of O 2 ), which lowers PAO 2 and consequently PecO 2 . Conversely, hyperventilation (increased ventilation relative to blood flow) increases PAO 2 and PecO 2 . PACO 2 is also determined by the V9A/Q9 ratio but CO 2 is delivered through blood flow and CO 2 is removed through ventilation, the converse of O 2 . Hence, a decreased V9A/Q9 ratio results in higher PACO 2 and PaCO 2 , the hallmark of hypoventilation, while an increased ratio lowers PACO 2 . These relationships are illustrated in figure 4 . The balance between O 2 delivery and removal results in a PAO 2 that can be quantified using the alveolar gas equation (box 1).
Hypoxaemia secondary to hypoventilation is, thus, due to a low PAO 2 and is the second cause of a low PaO 2 listed in table 2. Because there is no impairment of gas exchange across the alveolar-capillary membrane, 
Two-unit lung models
For the two remaining causes of hypoxaemia, both examples of V9A/Q9 mismatch, we must shift to multiunit lung models. While fascinating in its design and gas exchange capacity, the anatomical structure of the lung with multiple parallel gas exchanging units sets the stage for non-uniform and different distributions of regional ventilation and blood flow. If regional ventilation and perfusion are not perfectly matched, i.e. each unit is not receiving equal proportions of total blood flow and total ventilation, V9A/Q9 ratios will vary between lung regions, each of them will have different PAO 2 and PACO 2 and gas exchange will be less efficient. Figure 5 shows the range of PAO 2 and PACO 2 seen in units as a function of their V9A/Q9 ratio. To demonstrate how gas exchange becomes less efficient with units of differing V9/Q9 ratios, we will begin with a simple two-unit lung model.
BOX 1 Two versions of the alveolar gas equation
The alveolar equation exists in several forms; the upper version is easier to remember and is used in clinical practice. The lower version is more accurate because it corrects for the difference in inspiratory and expiratory minute volume when the respiratory exchange ratio, R, does not equal 1.0. The equation is used to calculate the alveolar-arterial O 2 difference (PA-aO 2 ). In the absence of diffusion limitation, V9A/Q9 mismatch and shunt (see text), PaO 2 equals PAO 2 . The PA-aO 2 can, therefore, be used as a measure of the overall deviation from perfect gas exchange. Figure 6 illustrates uniform distribution of blood flow but uneven distribution of ventilation to two units, such that one unit has a V9A/Q9 ratio of 2.0 while the other unit has a ratio of 0.1. The low V9A/Q9 ratio results in low PAO 2 in this unit and, thus, lower O 2 content and PecO 2 for blood leaving this unit. Note that the effect is analogous to that in the patient who was hypoventilating in case 2, but in this case it relates to only a part of the lung. The nearly complete oxygenation of haemoglobin at a normal V9A/Q9 ratio means that the relative over-ventilation (high V9A/Q9 ratio) of the other unit results in only a slightly increased O 2 content for blood leaving this unit. Also remember that the O 2 content of arterial blood (CaO 2 ) is determined by the flow-weighted mean of the O 2 contents, not partial pressures, for blood from different units. The overall effect of low V9A/Q9 units is, therefore, a reduced PaO 2 and an increased PA-aO 2 . Low V9A/Q9 units are, thus, the fourth cause of hypoxaemia (table 2). The effect of low V9A/Q9 units on PaCO 2 is less compared with the effect on PaO 2 , because CO 2 elimination is increased in the unit with a high V9A/Q9 ratio. In patients with low V9A/Q9 regions, hypercapnia is also prevented by the ventilatory response to increased PaCO 2 . Because low V9A/Q9 regions are in fact ventilated, the detrimental effect on arterial oxygenation can be counteracted by increasing the FIO 2 , which increases PAO 2 , even in low V9A/Q9 regions. Low V9A/Q9 units, therefore, cannot be the sole cause of hypoxaemia in patients that fail to respond to increased FIO 2 .
Shunt
In case 5, a 32-year-old male with severe acute respiratory distress syndrome (ARDS) secondary to bacterial pneumonia has an ABG on mechanical ventilation with an FIO 2 of 0.80 that reveals pH 7.28, PaO 2 67 mmHg (8.9 kPa) and PaCO 2 61 mmHg (8.1 kPa). Figure 7 shows a situation in which one unit is without any ventilation, hence it cannot participate in gas exchange. Blood flow through this unit, therefore, constitutes an intrapulmonary shunt. Shunt can be viewed as one extreme of the range of V9A/Q9 ratios with a ratio of 0. End-capillary blood flow from this unit has the same PecO 2 and CecO 2 as mixed venous blood and when combined with blood from the other unit decreases oxygenation of arterial blood. Shunt is, therefore, the fifth and last cause of hypoxaemia (table 2). The CaO 2 is again the flow-weighted average of O 2 content from the gas exchanging unit (CecO 2 ) and the shunted blood (Cec9O 2 ) ( fig. 7) . The amount of shunt is quantified as the fraction of cardiac output (Q9s/Q9t) distributed to nonventilated units (box 2). The effect on arterial oxygenation depends on this The shunt fraction has, however, been shown to increase with increasing cardiac output [13, 14] ; such interventions might therefore be less effective than expected. Increased PvO 2 and increased pulmonary arterial pressure, which may decrease and counteract hypoxic vasoconstriction (discussed later), are speculative explanations for this effect of cardiac output on shunt.
In contrast to the situation with low V9A/Q9 regions, with shunt increasing FIO 2 is much less effective at improving arterial oxygenation. With increasing shunt fraction, the effect of raising FIO 2 is progressively less and for very large shunts, even an FIO 2 of 1.0 has little effect on PaO 2 . The reasons for the small effect are that raised FIO 2 fails to improve PAO 2 in unventilated units and that the little extra O 2 that can be added to blood flow through ventilated units is not enough to offset the impact of the shunted blood. The relationships between the variables shunt size, FIO 2 and PaO 2 are illustrated by the iso-shunt diagram ( fig. 8) . Examples of clinical conditions with hypoxaemia due to large intrapulmonary shunts are extensive atelectasis, severe pneumonia and ARDS. In these conditions, the shunt might exceed 50% of total lung blood flow [13, [16] [17] [18] [19] ].
An intracardiac right-to-left shunt has the same effect on PaO 2 as an intrapulmonary shunt. Even in normal 
CecO2{CvO2
The shunt equation quantifies the amount of blood in the three-compartment model that reaches the left heart without exchanging any gases. The equation quantitates venous admixture as a fraction of total lung blood flow, i.e. cardiac output. Breathing an FIO 2 of 1.0 can be used to eliminate the impact of low V9A/Q9 units and, thus, calculate the true shunt. The equation is derived from principles of mass conservation, see for example [12] and figure 7. Notations are explained in table 1. CaO 2 and CvO 2 are obtained from samples of arterial and mixed venous blood, respectively; the latter requires a pulmonary artery catheter. CecO 2 is calculated assuming that PecO 2 equals that of ideal alveolar gas according to the alveolar gas equation. This equation can be conceptualised and graphically presented as shown in the vertical bar of figure 7 . CecO 2 at the top of the bar is the best the CaO 2 could be if there is no shunt at all. CvO 2 at the bottom of the bar is the worst the CaO 2 could be if all of the blood flow was through a shunt. The resultant CaO 2 is somewhere between the CvO 2 and the CecO 2 . The fraction of blood flow through the shunt ( Q9s/Q9t) is, therefore, the observed difference between the CecO 2 and CaO 2 divided by the potential greatest difference between CecO 2 and CvO 2 . subjects, PaO 2 is less than PAO 2 due primarily to a right-to-left shunt of 2-3% of cardiac output. Most of this is not a strict intrapulmonary shunt but represents venous blood added to arterial blood from bronchial veins and the Thebesian veins of the left ventricle [12] . The effect of shunt on CO 2 exchange is discussed in box 3.
Dead space
In a continuation of case 4, the 67-year-old female with severe emphysema is hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (COPD). ABG reveals pH 7.21, PaO 2 67 mmHg (8.9 kPa) and PaCO 2 85 mmHg (11.3 kPa). Measurements reveal she is breathing 12 L?min -1 .
Despite a minute ventilation (V9E) that is about twice what is normal at rest, this patient presents with an elevated PaCO 2 , indicating hypoventilation. How can this be explained? With each inspiration, in all subjects, part of the tidal volume (VT) is retained in the conducting airways and, therefore, fails to contribute to gas exchange. This volume corresponds to the anatomical dead space, and is ,150 mL (2-3 mL?kg
) or one third of a normal VT [12, 21] . A normal dead space fraction of the tidal volume (VD/VT) is therefore ,0.3. Figure 9 illustrates two units that are equally ventilated but one of the units is without blood 
FIGURE 9
Alveolar dead space illustrated by a two-unit model in which there is blood flow to only one unit while there is ventilation to both units. Because no gas exchange occurs in the unit without blood flow, PAO 2 and PACO 2 in this unit equal the inspired pressures. The dead space unit does not affect arterial blood gases because there is no blood flow contribution from this unit. The lack of CO 2 expired from the dead space region dilutes the concentration of CO 2 expired from the other unit and expired PCO 2 is thus lower than from perfused units. The degree by which the expired PCO 2 is decreased in comparison with PaCO 2 is proportional to the fraction of the lung that is dead space. The vertical bar to the right is a visual representation of the dead space equation (box 3). It is analogous to that in figure 7 and explained in the section on wasted ventilation. For a glossary of terms, see table 1.
BOX 3 Physiological dead space (Bohr) equation
V D V T~P aCO2{PĒ CO2
PaCO2
VD is the physiological dead space or wasted ventilation in the three-compartment model. The equation is derived from mass balance calculations that use the alveolar partial pressure of carbon dioxide (PACO 2 ), which is here replaced with PaCO 2 [20] . On exhalation, the PACO 2 from well perfused lung regions is diluted by the lack of CO 2 from the units of dead space. The degree to which the PĒCO 2 is reduced below the PaCO 2 is, thus, proportional to the amount of dead space. This concept is embodied in the vertical bar of figure 9 , where the PaCO 2 is at the top of the bar and represents the PĒCO 2 if there is no dead space at all. The PICO 2 at the bottom of the bar represents the PĒCO 2 if the entire lung were dead space. The resultant PĒCO 2 is between these two values. The fraction of wasted ventilation (VD/VT) is, therefore, the observed difference between PaCO 2 and PĒCO 2 divided by the potential greatest difference between PaCO 2 and PICO 2 . Because PICO 2 is zero, the denominator reduces to PaCO 2 alone. For a glossary of terms, see flow and, therefore, constitutes alveolar dead space. One clinical cause might be pulmonary embolism. Alveolar dead space refers to gas exchanging units that are ventilated but without blood flow and the V9A/Q9 ratio is infinite. Apparatus dead space refers to the volume of any face mask, tubing, etc. that functions as an extension of the anatomical dead space. Total dead space (VD), therefore, consists of summed anatomical dead space, alveolar dead space and any apparatus dead space.
Minute ventilation refers to the total volume of expired gas per minute, while effective alveolar ventilation refers to the volume of gas per minute that participates in gas exchange. In contrast, dead space ventilation, or wasted ventilation, is the fraction of total ventilation that does not contribute to gas exchange. This fraction of wasted ventilation is often expressed as the ratio VD/VT. Effective alveolar ventilation can be calculated as V9A5RR6(VT-VD), where RR is respiratory rate, or as V9A5V9E6(1-VD/VT). Note that effective alveolar ventilation is determined by both minute ventilation and VD/VT. Increased VD inherently means that a greater minute ventilation is needed to maintain effective alveolar ventilation adequate for CO 2 removal. An increase in VD/VT without a compensatory increase in minute ventilation results in decreased PaO 2 and increased PaCO 2 . In the patient in case 4, the high minute ventilation is not enough to compensate for the increased VD/VT, which results in hypercapnia. Increased PaCO 2 might also be seen in those sedated and mechanically ventilated patients who do not increase their minute ventilation in the setting of a new pulmonary embolism.
High V9A/Q9 units High V9A/Q9 units are units that are overventilated in proportion to blood flow, for example, a unit that receives a ventilation of 1 L?min -1 but a blood flow of only 0.1 L?min -1 resulting in a V9A/Q9 ratio of 10. Although this unit does not represent alveolar dead space, ventilation in excess of blood flow causes a ''dead space effect'', because less CO 2 will be removed by ventilation of a high V9A/Q9 unit than by ventilation of a better perfused region. Thus, similar to alveolar dead space, addition of high V9A/Q9 units means that a greater minute ventilation is needed to maintain adequate gas exchange. High V9A/Q9 regions are primarily due to areas of normal ventilation with low blood flow. The impact of these regions on ABGs is small, because the contribution of any region to ABG composition is flow-weighted.
More than two-unit lung models
So far we have focused on models with one or two lung units. In reality, gas exchange within the entire lung and the resulting PaO 2 and PaCO 2 are determined by the effluent blood flow from thousands of units with different V9A/Q9 ratios ( fig. 10 ). RILEY and COURNAND [9] suggested that the effect of V9A/Q9 mismatch on gas exchange can be more simply thought of and quantified as a lung consisting of only three compartments with different V9A/Q9 ratios: one compartment with ideal V9A/Q9 matching (V9A/Q951.0), one totally without ventilation (V9A/Q950, shunt) and one without blood flow (V9A/Q95', dead space).
The model is practical because it is relatively easy to obtain the measurements needed to quantify shunt blood flow and dead space ventilation (discussed below). It is important to understand that the calculations assume that the effects of V9A/Q9 mismatch on PaO 2 and PaCO 2 are entirely due to shunt and dead space ventilation, and that all gas exchange occurs in units with ideal V9A/Q9 matching. The model does not reflect the true situation as it ignores gas exchange in units with other V9A/Q9 ratios.
Venous admixture
With the three-compartment model, shunt blood flow is calculated using the shunt equation (box 2). The calculated shunt, alternatively and more accurately described as venous admixture, corresponds to the amount of right-to-left shunt of mixed venous blood that would result in the observed arterial oxygenation in the absence of low V9A/Q9 regions. Venous admixture might, therefore, be increased even in the absence of true shunt.
Using values obtained while breathing 100% O 2 can differentiate hypoxaemia due to low V9A/Q9 regions from the effect of a true shunt, because the venous admixture from low V9A/Q9 regions is abolished in this situation [12] . One problem with this approach is that breathing 100% O 2 tends to increase the amount of shunt due to absorption atelectasis so the degree of shunt while breathing a lower FIO 2 might be overestimated. Shunt can also be measured using inert gases with low solubility in blood [17, 22] . It should be noted that this methodology also differs from the calculation of venous admixture as it excludes the shunt effect of venous blood added to arterial blood after the passage through the lung, from Thebesian and bronchial veins.
Wasted ventilation (physiological dead space)
According to the three-compartment model of RILEY and COURNAND [9] , physiological dead space or wasted ventilation corresponds to the total dead space that would cause the observed impairment of CO 2 elimination (box 3). We prefer the term ''wasted ventilation'', since it better describes the meaning of this quantity. In normal lungs, the wasted ventilation closely corresponds to the anatomical dead space. In addition to anatomical dead space, wasted ventilation also results from any apparatus, alveolar dead space and high V9A/Q9 units. Blood from shunt regions will have a PecCO 2 equal to the mixed venous value, which raises PaCO 2 and thereby the calculated wasted ventilation; this has been coined shunt dead space [21] . This is an effect of using PaCO 2 as a surrogate for PACO 2 ; hence, while not an effect of increased dead space or high V9A/Q9 regions, it does represent impaired CO 2 elimination [23] . At expiration, the first part of the exhaled gas originates from the anatomical dead space where no gas exchange occurs. Therefore, this gas has the same PCO 2 as inspired gas, usually close to zero ( fig. 11) . After a short transitional phase consisting of a mixture of anatomical dead space and alveolar gas, the rest of the expiration consists of mixed alveolar gas. Measurement of PCO 2 of exhaled gas at the end of the expiration, PETCO 2 , has been used as a measure of mixed alveolar gas and as a noninvasive measure of PaCO 2 . There are, however, several considerations with this approach. In diseased lung the proportion of airflow from different lung regions might change during expiration, with different regions emptying sequentially rather than in parallel. In this situation, late emptying of low V9A/Q9 regions with a high PACO 2 causes the PCO 2 to increase throughout expiration and potentially be greater than the mean PACO 2 at the end of exhalation [24] . Even with healthy lungs, a similar phenomenon occurs when breathing with large tidal volumes during exercise [25, 26] . In this case, one important cause is that PACO 2 increases during the course of expiration due to more CO 2 being added to alveolar gas [27] . In these situations PETCO 2 might in fact even be greater than PaCO 2 , the upper limit being the PvCO 2 [24, 25] . Obviously, a PETCO 2 greater than the mixed PACO 2 will cause the PaCO 2 -PETCO 2 to underestimate wasted ventilation. of increased wasted ventilation in most situations is, therefore, not an increase in PaCO 2 but a change in minute ventilation and, therefore, the work of breathing. Chronic hypercapnia can be viewed as an adaptive response as it means that CO 2 removal can be maintained with a lower minute ventilation and, thus, lessens the work of breathing.
The arterial to end-tidal PCO 2 difference
The physiological dead space equation (box 3) uses the difference between PaCO 2 and the PCO 2 of mixed expired gas (PĒCO 2 ) to calculate the total fraction of wasted ventilation. By contrast, the difference between PaCO 2 and the PCO 2 of mixed expired alveolar gas excludes the effect of anatomical and apparatus dead space and, therefore, estimates the extent of high V9A/Q9 and alveolar dead space regions. Because the last part of the exhaled VT consists of alveolar gas (box 4), the end-tidal PCO 2 (PETCO 2 ) can be used as a surrogate measure of mixed PACO 2 . The PaCO 2 -PETCO 2 difference, therefore, correlates with dead space and wasted ventilation [28] [29] [30] . It is noteworthy that, remembering the physiological dead space equation, modelling studies have shown that (PaCO 2 -PETCO 2 )/PaCO 2 has a more linear correlation with alveolar dead space fraction than the simpler PaCO 2 -PETCO 2 [29, 30] . Although dependent on, for example, age, the inhaled/ exhaled gas volume and mode of ventilation, a PaCO 2 -PETCO 2 ,5 mmHg (0.7 kPa) is considered normal [31, 32] and is supported by PETCO 2 being close to 36 mmHg (4.8 kPa) in a small number of normal subjects [33] . PaCO 2 -PETCO 2 has been shown to correlate with alveolar dead space fraction and alveolar recruitment in animal models of ARDS [34] . PETCO 2 is illustrated in figure 11 and further discussed in box 4.
The combined effect of low and high V9A/Q9 regions In comparison with optimal V9A/Q9 matching, redistribution of either regional ventilation or blood flow must result in both low and high V9A/Q9 regions. For example, a shift in blood flow from one unit to another will cause one unit to be less perfused in proportion to ventilation (high V9A/Q9) and the other unit to be more perfused in proportion to ventilation (low V9A/Q9). Compared with the effect on PaCO 2 , the effect of V9A/Q9 mismatch on PaO 2 is often more obvious because 1) the numerical changes in PaO 2 are larger than those in PaCO 2 and 2) impaired CO 2 elimination is often counteracted by increased minute ventilation which offsets the effect of V9A/Q9 mismatch on PaCO 2 to a much greater degree than the effect on PaO 2 . The net effect of V9A/Q9 mismatch is always reduced gas exchange efficiency and for a given FIO 2 and minute ventilation results in lower PaO 2 and higher PaCO 2 than would have occurred if V9A/Q9 matching were optimal. 
FIGURE 11
Capnogram showing the PCO 2 of exhaled gas (vertical axis) plotted versus time (horizontal axis) during a single exhalation. Curve A corresponds to a theoretical curve from a single lung unit model in which the first part of the exhalation consists solely of anatomical dead space gas without CO 2 and the rest of the exhaled alveolar gas has a uniform PCO 2 that is equal to PACO 2 . In this single-unit model, PETCO 2 5PACO 2 5PaCO 2 . Curve B corresponds to a capnogram from a healthy individual with a normal amount of V9A/Q9 mismatching. Note that there would be a small difference between the PETCO 2 (marked with an open circle) and PaCO 2 . Curve C illustrates how increased V9A/Q9 causes the PCO 2 of exhaled gas to increase throughout expiration. In this case PETCO 2 even exceeds PACO 2 and possibly PaCO 2 . While this is not common, it can occur with slow exhalation of a large VT or at maximal exercise. Curve D illustrates a situation with increased alveolar dead space, resulting in an increased difference between PaCO 2 and PETCO 2 , as might be seen in a patient with a pulmonary embolism. For a glossary of terms, see V9A/Q9 mismatch in the normal lung
Regional ventilation and blood flow are not uniform in the normal lung. Heterogeneities of ventilation and perfusion have been attributed to the influence of airway and vascular tree geometries as well as regional differences in blood flow and lung compliance due to gravity [35] [36] [37] [38] [39] . The traditional zone model [38] of perfusion and ventilation predicts that both perfusion and ventilation increase in the gravitational direction, from apex to lung base in the upright posture. However, they do not increase at the same rate, and V9/Q9 tends to decrease from apex to base. Animal studies using higher spatial resolution measurements have suggested a fractal model [40, 41] , in which asymmetries in the vascular tree result in perfusion heterogeneities that cannot be explained by the hydrostatic gradient due to gravity. Regional ventilation and blood flow are further influenced by posture, lung volume and application of positive airway pressures [36, 37, 42] , to name just a few factors. Despite these non-uniformities, efficient gas exchange is possible through the close matching of ventilation and blood flow, attributed to the shared influences of structure and gravity [35] . The correlation is, however, not perfect, which causes V9A/Q9 ratios and, therefore, PAO 2 and PACO 2 , to vary between different lung regions [35] .
In young healthy individuals, most ventilation and blood flow are distributed to units with V9A/Q9 ratios between 0.3 and 2.0 [22] , which tends to result in a range of PAO 2 from about 90 mmHg to 130 mmHg ( fig. 5 ) [43] . With increasing age, ventilation and blood flow are distributed to units with a wider range of V9A/Q9 ratios, with blood flow to low V9A/Q9 regions being attributed to reduced ventilation of dependent lung regions due to airway closure [12, 44] . Consequently, PA-aO 2 increases with age [12, 44] .
Assessing arterial oxygenation
Several indices are used to evaluate PaO 2 in relation to FIO 2 . When breathing air, the PA-aO 2 provides a sensitive measure of gas exchange efficiency but is dependent on age. A number of different studies have sampled relatively small numbers of individuals in different populations to determine the distribution of PA-aO 2 in normal individuals [45] [46] [47] [48] . In all studies, the mean PA-aO 2 increases with age, as do the confidence intervals around the mean. Table 3 incorporates data from two of the larger populations [45, 46] . A simplified formula for the normal PA-aO 2 when breathing air is (age in years/4)+4 mmHg (divide result by 7.5 for kPa 
V9A/Q9 mismatch and vascular tone
Hypoxic pulmonary vasoconstriction Hypoxic pulmonary vasoconstriction (HPV) causes pre-capillary vasoconstriction in units with low PAO 2 (,60 mmHg (8.0 kPa)), such as those with low V9A/Q9 or shunt [51] [52] [53] [54] . The effect of HPV is to divert blood flow away from hypoxic units toward better ventilated units, improving V9A/Q9 matching and arterial oxygenation ( fig. 12 ). For example in humans, HPV reduces blood flow to atelectatic regions by ,50% [55, 56] ; the beneficial effect on arterial oxygenation can be deduced from moving from one iso-shunt line to another at a fixed FIO 2 in the iso-shunt diagram ( fig. 8 ). The efficacy of HPV in correcting V9A/Q9 mismatch decreases with the extent of the hypoxic lung region [53, 57] . One example is low PAO 2 within the entire lung (e.g. due to severe hypoventilation or high altitude). In this case, generalised vasoconstriction raises pulmonary arterial pressure without improving V9A/Q9 matching. Animal and human experiments indicate that HPV is of little importance for V9A/Q9 matching in normal lungs [53, 58, 59] . By contrast, HPV can be of critical importance in patients with disease causing regional alveolar hypoxia [53] , improving PaO 2 by up to 20 mmHg (2.7 kPa) in patients with COPD or ARDS [54] . An illustration of the importance of HPV is that systemically administered vasodilators, inhibiting HPV, might reduce PaO 2 in such patients [60] .
Supplemental oxygen and carbon dioxide retention in COPD patients
One further illustration of the clinical importance of HPV is its role in O 2 -induced hypercapnia in patients with COPD. Although often attributed to a decreased drive to breathe, it has been shown that administration of supplemental O 2 to these patients can increase PaCO 2 despite constant minute ventilation [61, 62] . The major explanation is that supplemental O 2 raises the PAO 2 in low V9A/Q9 units, inhibiting regional HPV and increasing blood flow to these units. Consequently, blood is diverted away from better ventilated regions, converting them to high V9A/Q9 units, which increases wasted ventilation [61, 62] . This is an illustration of how increased wasted ventilation decreases effective alveolar ventilation (discussed above), despite unchanged minute ventilation. In addition, because the low V9A/Q9 units have a higher PACO 2 , the restored blood flow to these units results in more CO 2 being delivered to the arterial blood. Increased V9A/Q9 mismatch as the dominant mechanism causing O 2 -induced hypercapnia remains, however, controversial: other work has shown that decreased minute ventilation can contribute to increased PaCO 2 [63] . One further explanation is the Haldane effect, in which increased PaO 2 decreases binding of both H + and CO 2 to haemoglobin, thereby increasing the amount of physically dissolved CO 2 and, thus, PCO 2 [12, 64] . In other words, for any given CO 2 content, PCO 2 will be higher with greater haemoglobin O 2 saturation. The Haldane effect has been estimated to explain 6-78% of the increase in PaCO 2 in COPD patients after administration of supplemental O 2 [61, 65, 66] . FIGURE 12 Hypoxic pulmonary vasoconstriction (HPV) occurs in lung regions with low PAO 2 , effectively redistributing blood flow away from the hypoxic regions and towards better oxygenated regions. The distribution of ventilation is identical to that in figure 6 but blood flow to the low V9A/Q9 unit is halved due to HPV. Compare with figure 6 to see the effect of this redistribution of blood flow on gas exchange. Because ventilation is not altered, the V9A/Q9 ratios change such that the hypoxic region has an increased V9A/Q9 ratio, increasing the PAO 2 in that region. With more blood flow coming from the well ventilated region, with the higher PAO 2 , CaO 2 and PaO 2 are markedly improved. For a glossary of terms, see 
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Inhaled vasodilators
Inhaled vasodilators can be used to improve V9A/Q9 mismatch. The concept is that inhaled vasodilators are distributed to each region in proportion to regional ventilation and well ventilated regions are, therefore, more vasodilated. Locally reduced vascular tone causes a shift in blood flow away from unventilated regions toward the better ventilated regions, improving V9A/Q9 matching and gas exchange. Inhaled nitric oxide has been shown to reduce shunt [60, 67] and improve arterial oxygenation in patients with ARDS [60, 68, 69] .
A similar effect has been demonstrated with inhaled prostacyclin [70, 71] . Interestingly, the effect is less consistent in patients with COPD. In this case, inhaled nitric oxide can result in both improved and worsened gas exchange; the latter can be explained by the vasodilator also reaching low V9A/Q9 regions. Inhibition of HPV increases blood flow to these low V9A/Q9 regions, which causes further arterial desaturation [67, 72] . The beneficial effect of inhaled nitric oxide might, therefore, be less consistent in hypoxaemia caused by low V9A/Q9 regions than in conditions characterised by shunt regions.
V9A/Q9 mismatch in lung diseases COPD Patients with COPD might present with hypoxaemia, hypercapnia or both. Hypoxaemia is primarily explained by perfusion of underventilated (low V9A/Q9) regions, which has been attributed to airway disease [73] [74] [75] [76] . Shunt is of little importance in the absence of complicating conditions such as pneumonia or atelectasis [7, 74] and hypoxaemia is, therefore, expected to respond to increased FIO 2 . Hypercapnia is explained by decreased effective alveolar ventilation due to increased wasted ventilation secondary to high V9A/Q9 regions and alveolar dead space caused by emphysematous destruction of the lung parenchyma [73] [74] [75] . Hypercapnia becomes evident only when the patient is unable to maintain the added work of breathing required for adequate alveolar ventilation. Changes in cardiac output, O 2 consumption and minute ventilation have been shown to modulate the effect of increased V9A/Q9 mismatch in patients with acute COPD exacerbations [74] .
ARDS
Gas exchange in patients with ARDS, often caused by pneumonia or sepsis, is characterised by severe hypoxaemia due to loss of aeration of large lung regions. Several studies have shown that arterial hypoxaemia in these patients is mostly caused by shunt blood flow that might exceed 50% of cardiac output [13, [16] [17] [18] [19] . Low V9A/Q9 regions are either absent or a lesser cause of low PaO 2 [16, 17] . Impaired diffusion does not seem to contribute to arterial hypoxaemia [16] . The effect of PEEP on V9A/Q9 mismatch in these patients is especially interesting. PEEP has been shown to reduce the amount of nonaerated lung tissue through alveolar recruitment and to improve arterial oxygenation through a decrease in shunt blood flow [13, 16, 17, 19, 77, 78] . Increased PEEP has also been shown to increase total dead space, which is interpreted as an increased number of unperfused alveoli secondary to increased airway pressure with compression of alveolar capillaries in nondependent lung regions [16, [77] [78] [79] . The effect of PEEP on dead space is attenuated if the negative effect of PEEP on cardiac output is counteracted by fluid loading to increase cardiac preload, which also illustrates that reduced cardiac output might increase VD/VT [79] . By contrast, PEEP in combination with alveolar recruitment has been shown to decrease wasted ventilation [80] . When using PEEP to optimise gas exchange in these patients it is, thus, necessary to balance the potential beneficial and detrimental effects on oxygenation, wasted ventilation and cardiac output. Another tool to improve gas exchange in ARDS patients is treatment in the prone posture. Animal experiments and clinical studies have demonstrated that the prone posture decreases shunt and V9A/Q9 mismatch, improving arterial oxygenation [81] [82] [83] . A recent clinical trial demonstrated that the use of the prone posture early in the course of ARDS was associated with improved survival [84] . The primary mechanism postulated to increase survival is not improved gas exchange, but a more uniform distribution of regional ventilation resulting in less ventilator-induced lung injury [83, 85] .
Pulmonary embolism
Pulmonary embolism results in lung regions with no or reduced blood flow (high V9A/Q9 regions) and, thus, increased wasted ventilation. Less obviously, redistribution of blood flow to other lung regions causes these regions to become relatively overperfused, and transformed into low V9A/Q9 regions, creating hypoxaemia and an increased PA-aO 2 . The reason for hypoxaemia is, thus, increased V9A/Q9 mismatch but not increased shunt [86, 87] . The effect on ABGs is modified by the respiratory response to increased PaCO 2 , the end result often being a dyspnoeic patient with hypoxaemia and normal or even low PaCO 2 . Hypoxaemia might be aggravated by circulatory failure causing low CvO 2 or by intracardiac right-to-left shunting, both provoked by acute pulmonary hypertension. Importantly, the absence of hypoxaemia or increased PA-aO 2 does not rule out pulmonary embolism [88, 89] . Similarly, using the PaCO 2 -PETCO 2 to gauge wasted ventilation is informative, but in isolation is not definitive for diagnosing pulmonary embolism [90] . While a PETCO 2 measurement indicating increased wasted ventilation increases the likelihood of pulmonary embolism [91] and a normal amount of wasted ventilation diminishes the likelihood [33, 92] , the utility of these measures is very dependent on the a priori clinical probability of pulmonary embolism in the individual patient [90] and the fraction of the pulmonary vascular tree that is involved [91] .
Summary
1) There are five cause of hypoxaemia. Decreased PaO 2 can be caused by hypoventilation, low PIO 2 , diffusion limitation, low V9A/Q9 regions or shunt. In contrast with other causes, hypoxaemia due to shunt characteristically responds poorly to increased FIO 2 . Low V9A/Q9 regions and shunt are by far the most common causes of clinically encountered hypoxaemia.
2) Hypoventilation and low V9A/Q9 regions also impair CO 2 removal, but the magnitude of the effect on PaCO 2 is less and modified by the ventilatory response to hypercapnia.
3) High V9A/Q9 regions and alveolar and apparatus dead space cause increased wasted ventilation and, thus, impaired CO 2 elimination. The primary response to increased wasted ventilation is, in most situations, increased minute ventilation and work of breathing, not increased PaCO 2 .
4) The effect of V9A/Q9 mismatch on gas exchange efficiency can be quantified using calculations of PA-aO 2 , venous admixture and wasted ventilation.
5) Low and high V9A/Q9 regions cause hypoxaemia, impaired CO 2 elimination and increased work of breathing in COPD patients.
6) Shunt is the most important cause of hypoxaemia in patients with ARDS and pneumonia.
